Sir, While there is rightly much excitement about the potential of weight-loss drugs, they can never be the only solution to our obesity crisis (“Weight loss jab reduces heart deaths by a fifth”, May 14). Getting access to this new generation of medication, as part of a holistic package of support, is the first hurdle our policymakers need to address, as weight management services are badly fragmented, and those seeking support face record waiting lists.
In the short term, access to weight-loss treatments should be prioritised for those with the greatest clinical need. But more than this, preventing obesity by addressing the underlying causes of it is essential to help more people to maintain a healthy weight and reduce their risk of developing
